Skip to content

Internet Buzzing About Exelisis’ Orphan Drug Cabozantinib For Medullary Thyroid Cancer

December 1, 2012

      The Internet is buzzing about Exelisis’ orphan drug Cabozantinib for Medullary Thyroid Cancer (MTC) :  

1)  FDA November 29, 2012 Press Release  

2)  Elsevier Business Intelligence “The Pink Sheet Daily” November 30, 2012 article titled, “Exelixis Explains Virtues Of Flat Pricing For Cometriq” (Subscription May Be Required)  

3)  Bloomberg BusinessWeek.com November 30, 2012 article titled, “Exelixis declines despite cancer drug approval”  

4)  The Motley Fool November 30, 2012 article titled, “Exelixis’ Crowning Achievement”  

5)  MarketWatch.com November 29, 2012 article titled, “Exelixis Announces EMA Acceptance of Marketing Authorization Application for Cometriq (Cabozantinib)”.  

        As of December 1, 2012, CafePharma.com, a website for pharmaceutical and medical sales professionals, has a “Social Media Monitoring Page for Exelixis” reporting the following statistics :  

–          # of Twitter tweets in the last 24 hours = 100 

–          Average Twitter tweets per    24 hours =   52.   

        On November 27, 2012, the Orphan Druganaut Blog, reports that CafePharma.com’s “Social Media Monitoring Page for Exelixis” reports the following statistics as of that date :  

–          # of Twitter tweets in the last 24 hours = 85 

–          Average Twitter tweets per    24 hours =   11.  

       On November 26, 2012, the Orphan Druganaut Blog, reports that CafePharma.com’s “Social Media Monitoring Page for Exelixis” reports the following statistics as of that date :   

–          # of Twitter tweets in the last 24 hours = 49 

–          Average Twitter tweets per    24 hours =   6.   

Copyright © 2012-2013, Orphan Druganaut Blog.  All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: